What is the prognosis for someone with a chordoma?

There is a high rate of recurrence. Those diagnosed with chondroid chordomas tend to have a better prognosis than either conventional or classic chordomas. Dedifferentiated chordomas tend to grow faster and will more often grow elsewhere (metastasize). The outlook for dedifferentiated chordomas is the least optimistic.

Younger patients are more likely to develop metastatic disease. Recurrence is linked to metastasis. Survival rates depend on the location of the tumor and location of metastasis.

Last reviewed by a Cleveland Clinic medical professional on 09/05/2018.

References

  • Chauhan A, Ahluwalia V, Saharan P, Sharma N, Narayan S, Gupta R. RADIOLOGICAL CASE. Clival chordoma in a young child. Applied Radiology [serial online]. November 2017;46(11):37-41.
  • Thompson L. Chordoma. ENT: Ear, Nose & Throat Journal [serial online]. January 2011;90(1):16-18.
  • Tsuji T, Chiba K, Matsumoto M, et al. Differentiation of spinal giant cell tumors from chordomas by using a scoring system. European Journal Of Orthopaedic Surgery & Traumatology [serial online]. October 2016;26(7):779-784.
  • Young V, Curtis K, Temple H, Eismont F, DeLaney T, Hornicek F. Characteristics and Patterns of Metastatic Disease from Chordoma. Sarcoma [serial online]. December 30, 2015;:1-7.
  • Sawke G K, Sawke NG. Sacrococcygeal chondroid chordoma: A case report with brief literature review. Clin Cancer Investig J 2014;3:116-8
  • George B, Bresson D, Herman P, Froelich, S. Chordomas: A Review. Neurosurgery Clinics of North America, 2015-07-01, Volume 26, Issue 3, Pages 437-452, Copyright © 2015 Elsevier Inc.
  • Chordoma Foundation. Understanding Chordoma. Accessed 9/14/2018.
  • Bone Cancer Research Trust. Chordoma. Accessed 9/14/2018.

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy